Biolargo Inc
(BLGO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 17,779 | 12,230 | 5,884 | 2,531 | 2,432 |
| Cost of Goods | 9,926 | 6,076 | 3,027 | 1,428 | 1,204 |
| Gross Profit | 7,853 | 6,154 | 2,857 | 1,103 | 1,228 |
| Operating Expenses | 13,110 | 10,810 | 8,274 | 8,309 | 9,015 |
| Operating Income | -4,331 | -4,580 | -5,390 | -6,778 | -7,583 |
| Interest Expense | 33 | 91 | 53 | 234 | 1,923 |
| Other Income | 17 | 23 | 311 | 118 | -194 |
| Pre-tax Income | -4,347 | -4,648 | -5,132 | -6,894 | -9,700 |
| Net Income Continuous | -4,347 | -4,648 | -5,132 | -6,894 | -9,700 |
| Minority Interests | -1,945 | -1,144 | -659 | 186 | -1,268 |
| Net Income | $-2,402 | $-3,504 | $-4,473 | $-7,080 | $-8,432 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.02 | -0.03 | -0.05 |
| EPS Basic Continuous Ops | -0.01 | -0.02 | -0.02 | -0.03 | -0.05 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.02 | -0.03 | -0.05 |
| EPS Diluted Continuous Ops | -0.01 | -0.02 | -0.02 | -0.03 | -0.05 |
| EPS Diluted Before Non-Recurring Items | -0.01 | -0.02 | N/A | -0.03 | -0.05 |
| EBITDA(a) | $-4,076 | $-4,308 | $-5,345 | $-6,758 | $-7,525 |